Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine mouthwash for inhibition of dental plaque formation
2017-001698-18Phase 3Completed
- Sponsor
- Schülke & Mayr
- Start
- Jun 2017
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dental plaque comparing 0.1% octenidine mouthwash with Placebo (2 arms). Primary endpoint: Total mean plaque index after 5 days. Started Jun 2017; status: completed.
02
Drugs
octenidine
03
Conditions
dental plaque
Beyond the preview
Go deeper on 2017-001698-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001698-18.